Filing Details
- Accession Number:
- 0001384101-22-000113
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-09 17:16:29
- Reporting Period:
- 2022-08-05
- Accepted Time:
- 2022-08-09 17:16:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1384101 | Veracyte Inc. | VCYT | Services-Medical Laboratories (8071) | 205455398 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1769333 | C Giulia Kennedy | 6000 Shoreline Court Suite 300 South San Francisco CA 94080 | Chief Scientific & Med Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-08-05 | 10,702 | $0.00 | 71,055 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2022-08-05 | 2 | $10.45 | 71,057 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-08-05 | 2 | $6.45 | 71,059 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-08-05 | 1 | $5.43 | 71,060 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-08-05 | 1,028 | $26.54 | 70,032 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Acquisiton | 2022-08-05 | 18,248 | $0.00 | 18,248 | $27.90 |
| Common Stock | Stock Option (right to buy) | Disposition | 2022-08-05 | 2 | $0.00 | 2 | $10.45 |
| Common Stock | Stock Option (right to buy) | Disposition | 2022-08-05 | 2 | $0.00 | 2 | $6.45 |
| Common Stock | Stock Option (right to buy) | Disposition | 2022-08-05 | 1 | $0.00 | 1 | $5.43 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 18,248 | 2032-08-05 | No | 4 | A | Direct | |
| 0 | 2024-09-15 | No | 4 | M | Direct | |
| 0 | 2026-02-28 | No | 4 | M | Direct | |
| 0 | 2026-03-14 | No | 4 | M | Direct |
Footnotes
- Restricted stock units awarded on August 5, 2022 vest 1/3rd on September 2, 2023 and 1/12th per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date.
- The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022.
- The option becomes exercisable as to 1/3rd of the shares on August 5, 2023, and the remaining shares vest at a rate of 1/36th of the total number of shares subject to the award for each month of continuous service thereafter.
- The option is fully vested.
Billionaire Hedge Funds
